News: Biotechnology  |  Nanotechnology  |  Pharmaceutical  |  >Clinical Trials  |  Genetics

Clinical Trials News Today is November 21, 2009. All times in Eastern Time. 11/20/2009 - 06:50 PM U.S. Food and Drug Administration Approves ABILIFY® (aripiprazole) for the Treatment of Irritability Associated with Autistic Disorder in Pediatric Patients (Ages 6 to 17 Years) 11/20/2009 - 04:17 PM Lupus Foundation of America Web Chat to Focus on Medication Adherence 11/20/2009 - 01:18 PM Pfizer Receives FDA Approval For Geodon® (Ziprasidone HCI) Capsules For The Adjunctive Maintenance Treatment Of Bipolar Disorder In Adults 11/20/2009 - 09:01 AM EKR Therapeutics Named Private Company of the Year By New Jersey Technology Council 11/20/2009 - 08:30 AM FDA Approves Intravenous Formulation Of Pfizer’s Revatio® (Sildenafil) For The Treatment Of Pulmonary Arterial Hypertension 11/20/2009 - 08:30 AM POZEN Announces Start of Enrollment For PA32540 Phase 3 Program 11/20/2009 - 08:04 AM Genasense® Given as High-Dose IV Infusion with Chemotherapy Shows Promising Activity in Advanced Melanoma 11/20/2009 - 08:00 AM Ligand Presents New Preclinical Data on its Lead SARM Molecule LGD-4033 at the Gerontological Society of America Annual Meeting 11/20/2009 - 07:30 AM FDA Extends Review of NDA for Exalgo™ 11/20/2009 - 06:00 AM Inovio Biomedical Universal Flu Vaccines Demonstrate Broadly Protective Immune Responses Against Multiple Seasonal & Pandemic Influenza Viruses in Pre-Clinical Studies 11/20/2009 - 05:00 AM The New Face of Formatech.com 11/19/2009 - 04:57 PM Correction: ZOLL Medical Awarded Federal Supply Schedule Contract for Intravascular Temperature Management 11/19/2009 - 04:31 PM KineMed Receives an Investigator-Initiated Study Grant to Further Explore Mechanism(s) of Action Associated with Welchol® (colesevelam HCl) in Type 2 Diabetes Mellitus 11/19/2009 - 04:05 PM Sucampo Receives Marketing Authorization for Amitiza® in Switzerland for Treatment of Chronic Idiopathic Constipation 11/19/2009 - 04:03 PM SeraCare Reports Fourth Quarter and Fiscal Year 2009 Results 11/19/2009 - 01:38 PM Cobalis Corp, Maker of Revolutionary Allergy Relief Product PreHistin® “The World’s FIRST Prehistamine” Confirms Filing of Five Count Lawsuit Against Yorkville Advisors/YA Global Investments, L P f/k/a Cornell Capital Partners, L P in US Bankruptcy Court 11/19/2009 - 10:00 AM Advanced Cell Technology Files IND With FDA For First Human Clinical Trial Using Embryonic Stem Cells to Treat Eye Disease 11/19/2009 - 10:00 AM Acurian Announces Licensing Agreement with i3 for Clinical Research Site Selection Services 11/19/2009 - 10:00 AM AcroMetrix Announces the Launch of the OptiQual® HPV Genotype Panel 11/19/2009 - 09:03 AM Nutra Pharma Introduces Chronic Pain Reliever, Nyloxin OTC, for International Distribution 11/19/2009 - 08:59 AM ImmunoCellular Therapeutics Issues Letter to Shareholders 11/19/2009 - 08:00 AM Pluristem Therapeutics Presents Three Month Follow-Up Data from First Patient to Receive Placental Derived PLX-PAD at Two Meetings in Germany and France 11/19/2009 - 08:00 AM Cardiovascular Systems Enrolls First Patient in CALCIUM 360° Clinical Trial 11/19/2009 - 08:00 AM Altair Therapeutics Announces Commencement of a Multi-Center Phase IIa Clinical Trial of Inhaled AIR645 to Treat Asthma 11/19/2009 - 07:30 AM Geron Presents Interim Clinical Data on Its Telomerase Inhibitor Drug at AACR-NCI-EORTC 1 2 3 4 5   Next »

Terms of Use   |   ©2009 Business Wire